Pre-exposure prophylaxis medications used for HIV prevention do not inherently cause dramatic changes in body shape or physical physique for the vast majority of users. Clinical trials and long-term health studies have shown that modern PrEP formulas are generally weight-neutral. While some individual users report minor weight fluctuations or mild gastrointestinal adjustments when first starting the medication, these bodily changes are typically minimal. Unlike older antiretroviral drugs utilized for HIV treatment decades ago, which were associated with fat redistribution syndromes, current preventative PrEP pills and injections do not cause significant alterations to body fat distribution or muscle mass.
1 votes
Marked as accepted